Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

MLA

Lydia Gaba, et al. Efficacy and Safety of Trabectedin in Metastatic Uterine Leiomyosarcoma: A Retrospective Multicenter Study of the Spanish Ovarian Cancer Research Group (GEICO). Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3e405505665cff59421dd36ce406f11b&authtype=sso&custid=ns315887.

APA

Lydia Gaba, Pilar Barretina, María Eugenia Ortega, María José Lecumberri, M. J. Rubio, Jaime Espinós, Julia Calzas, Silvia Varela, Ana Santaballa, Gloria Marquina, Jesús Alarcón, & Isabel Ruiz. (2020). Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO).

Chicago

Lydia Gaba, Pilar Barretina, María Eugenia Ortega, María José Lecumberri, M. J. Rubio, Jaime Espinós, Julia Calzas, et al. 2020. “Efficacy and Safety of Trabectedin in Metastatic Uterine Leiomyosarcoma: A Retrospective Multicenter Study of the Spanish Ovarian Cancer Research Group (GEICO),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3e405505665cff59421dd36ce406f11b&authtype=sso&custid=ns315887.